Tag: $Hims & Hers

Novo Nordisk A/S plans to sell its weight-loss drugs on Hims & Hers Health Inc.’s platform, according to a person familiar with the matter, ending a highly public feud between the two companies that spiraled into a legal battle last month.

Hims & Hers Health (HIMS) stock fell after the telehealth company posted mixed quarterly results and issued a weak outlook for the current quarter.

Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity pill and injections in the U.S.

The stock of Hims & Hers dropped in premarket trading early Friday after a legal threat from Novo Nordisk.

Hims & Hers Health (NYSE:HIMS) stock plunged 20% after pharmaceutical giant Novo Nordisk (NYSE:NVO) announced it would terminate its collaboration with the telehealth company over the sale of weight loss drugs.

Hims & Hers Health announced Tuesday it will acquire European telehealth platform Zava in its push to expand globally.

Hims & Hers stock HIMS+1.39% jumped after the telehealth company that has built a business around selling copycat weight-loss drugs announced a deal with Ozempic-maker Novo Nordisk.